Word

OUTPUT

Status

Pending

Status Code

661

Status Date

Wednesday, September 4, 2024

Serial Number

97617393

Mark Type

4

Filing Date

Monday, October 3, 2022

Trademark Owner History

OUTPUT BIOSCIENCES INC. - 1st New Owner Before Publication
Jingu Health Inc. - Original Applicant

Classifications

5 Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for preventing or treating diseases in a human subject, using targeted bioactives for the modulation of disturbed microbial ecosystems; Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for preventing or treating diseases in a human subject, via targeted modulation of a host microbial community; Therapeutics, pharmaceuticals, preventative therapies and nutraceuticals for the prevention and treatment of human diseases, namely, Autoimmune diseases and disorders, Bone and joint diseases and disorders, Cancer, Cardiovascular diseases and disorders, Gastro-intestinal diseases and disorders, Hematologic diseases and disorders, Infectious diseases and disorders, Kidney diseases and disorders, Lung diseases and disorders, Metabolic diseases and disorders, Muscle diseases and disorders, Nephrology diseases and disorders, Neurodegenerative diseases and disorders, Neurological diseases and disorders, Ophthalmic diseases and disorders, Dermatological diseases and disorders, Inflammatory diseases and disorders, Immune disorders, Allergic disorders, Immuno-oncology and improving therapy outcome of Immuno-oncology therapies, Psychiatric diseases and disorders, Digestive diseases and disorders, Nutritional diseases and disorders, Malnutrition, Vaginal and penile diseases and disorders, Dysbioses, Fertility

42 Computational biology platform for preventative therapies and nutraceuticals, namely non-downloadable software in the field of computational biology for use in the discovery, design, and optimization of therapeutics, pharmaceuticals, preventative therapies, and nutraceuticals; Computational biology platform for preventative therapies and nutraceuticals, namely, non-downloadable software in the field of computational biology for use in the research, development, and identification of disease mechanisms and therapeutic targets within the human microbiome; Computational biology platform for preventative therapies and nutraceuticals, namely, non-downloadable software in the field of computational biology for use in designing, forecasting results, running, and monitoring clinical trials, and selecting clinical trial participants, all related to clinical trials for therapeutics, pharmaceuticals, preventative therapies and nutraceuticals; Product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents, and nutraceuticals; research and development of therapeutics related to preventative therapies, pharmaceuticals, and nutraceuticals

Trademark Events

Oct 20, 2022

New Application Office Supplied Data Entered

May 3, 2023

Automatic Update Of Assignment Of Ownership

Jul 18, 2023

Assigned To Examiner

Jul 27, 2023

Non-Final Action Written

Jul 27, 2023

Non-Final Action E-Mailed

Jul 27, 2023

Notification Of Non-Final Action E-Mailed

Oct 24, 2023

Application Extension To Response Period - Received

Oct 24, 2023

Application Extension Granted/Receipt Provided

Jan 29, 2024

Teas Response To Office Action Received

Jan 29, 2024

Correspondence Received In Law Office

Jan 30, 2024

Teas/Email Correspondence Entered

Mar 4, 2024

Non-Final Action Written

Mar 4, 2024

Non-Final Action E-Mailed

Mar 4, 2024

Notification Of Non-Final Action E-Mailed

May 31, 2024

Application Extension To Response Period - Received

Sep 4, 2024

Correspondence Received In Law Office

Sep 4, 2024

Teas/Email Correspondence Entered

Sep 4, 2024

Teas Response To Office Action Received

May 31, 2024

Application Extension Granted/Receipt Provided